Med Caelyx resulterer indkapslingen af doxorubicin i pegylerede liposomer i, at disse virkninger har en anden styrke, som angivet nedenfor.
With Caelyx, the encapsulation of doxorubicin hydrochloride in pegylated liposomes results in these effects having a differing strength, as follows.